Literature Highlights - February 2022

This highlight deck is comprised of 6 papers

Keywords:

Belimumab, Lupus nephritis, BLISS, Anifrolumab, Severe SLE, TULIP trials, Organ domains, BILAG, EULAR, CV risk, Antimalarials, B-cell subset, IgG

LinkedIn